FNWB:NASDAQFirst Northwest Bancorp Analysis
Data as of 2026-07-08 - not real-time
$11.17
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
First Northwest Bancorp (FNWB) is trading around $11.17, comfortably above its 20‑day and 50‑day SMAs and showing a bullish MACD crossover. The RSI sits in the high‑60s, indicating strong momentum without being severely overbought, while volume remains stable and beta is low, suggesting defensive behavior.
Valuation metrics reveal a substantial gap between market price and intrinsic value. The DCF‑derived fair value exceeds $28, and analysts’ median target of $13.25 implies roughly an 18% upside. A price‑to‑book of 0.63, a 2.9% dividend yield with a modest 13% payout, and 66% revenue growth underscore a blend of value and growth appeal, further supported by the recent appointment of a veteran chief banking officer to drive operational excellence.
Valuation metrics reveal a substantial gap between market price and intrinsic value. The DCF‑derived fair value exceeds $28, and analysts’ median target of $13.25 implies roughly an 18% upside. A price‑to‑book of 0.63, a 2.9% dividend yield with a modest 13% payout, and 66% revenue growth underscore a blend of value and growth appeal, further supported by the recent appointment of a veteran chief banking officer to drive operational excellence.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish technical setup (price above SMAs, MACD bullish)
- Support level intact and volatility moderate
- Attractive short‑term upside to resistance
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant valuation discount to DCF and analyst targets
- Strong revenue growth and sustainable dividend yield
- Leadership change expected to enhance earnings execution
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Long‑run undervaluation with a wide margin of safety
- Low beta and defensive balance‑sheet profile
- Consistent dividend with low payout supporting cash‑flow stability
Key Metrics & Analysis
Financial Health
Revenue Growth66.40%
Profit Margin7.23%
P/E Ratio20.3
ROE3.20%
ROA0.22%
P/B Ratio0.6
Op. Cash Flow$19.9M
Industry P/E17.7
Technical Analysis
TrendBullish
RSI68.8
Support$9.90
Resistance$11.51
MA 20$10.59
MA 50$10.13
MA 200$9.51
MACDBullish
VolumeStable
Fear & Greed Index92.63
Valuation
Fair Value$28.83
Target Price$13.25
Upside/Downside18.62%
GradeUndervalued
TypeGrowth
Dividend Yield2.90%
Risk Assessment
Beta0.52
Volatility25.37%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.